Articles from DNAnexus

DNAnexus today announced it has been named to the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. The list is the most prestigious ranking of the nation’s prominent independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia.

Today, DNAnexus, the world’s most trusted platform for omics data enablement, announced it has achieved a 90% customer satisfaction score (CSAT) — a milestone underscoring the trust that the world's leading biopharma, diagnostic, and health system organizations place in the platform as DNAnexus continues to achieve global scale and accelerate growth.

Today, DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel.

DNAnexus, the enterprise leading orchestration platform for precision health, today announced it has received the PharmaTech Innovation Award as part of the 10th annual MedTech Breakthrough Awards. This accolade honors DNAnexus as a catalyst in precision medicine, recognizing its AI-enabled platform for its ability to transform raw multimodal data into scientific discovery and underscoring its transformative impact on the global biopharma ecosystem.

Oracle Health and Life Sciences Summit — DNAnexus, Inc., global provider of the leading enterprise platform for precision health data, today announced its intention to bring precision medicine capabilities to select Oracle Health clinical applications.

DNAnexus, the leader in regulatory cloud services, today announced it will expand its relationship with Veeva to advance global regulatory collaboration in the cloud. This includes working toward integrating Veeva RIM and DNAnexus Trusted Regulatory Spaces (TRS), furthering DNAnexus’ commitment to advancing regulatory research and review in the cloud through trusted global sponsor, agency, and standards development organization collaboration.

DNAnexus, Inc., provider of the Precision Health Data Cloud, and Galatea Bio, committed to 'Precision Health at Scale for All,' today announced a strategic collaboration to enhance biomedical research and precision medicine, particularly for Latin American populations and other underserved groups. The collaboration will combine Galatea’s specialized data and DNAnexus' cloud capabilities to increase access to advanced genetic tools that can improve diagnostic testing, accelerate drug discovery, and optimize health outcomes.

DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, today announced a collaboration to help streamline Discovery’s next-generation sequencing data analysis. Discovery operates one of the world’s largest commercial genome centers that brings together advanced technologies and in-house experts to collaboratively plan data strategies that deliver high-quality results rapidly for biopharmaceutical clients’ projects of any scale. As part of the agreement, Discovery will use the DNAnexus cloud and analysis tools to optimize analysis pipeline performance, mitigate risk, and accelerate project turnaround times.